TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has provided an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has approved a Board Diversity Policy to enhance corporate governance and support sustainable development. This policy emphasizes the importance of diversity in the boardroom, considering factors such as gender, age, cultural background, and professional experience in the selection of board members. The Nomination and Remuneration Committee is tasked with ensuring the implementation of this policy, with the aim of achieving a balanced and effective board composition. The company will report annually on the board’s diversity and the policy’s implementation, reflecting its commitment to inclusivity and strategic growth.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is committed to enhancing its corporate governance and promoting sustainable development within the industry.
Average Trading Volume: 1,602,703
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.28B
See more data about 0874 stock on TipRanks’ Stock Analysis page.